U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8349183491Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular DegenerationCompletedNo Results AvailableExudative Macular Degeneration|Diabetic Macular EdemaDrug: Avastin|Drug: Avastin|Drug: Lucentishttps://ClinicalTrials.gov/show/NCT01473251
8349283492Desktop Versus Mobile Data Collection in Clinical TrialNot yet recruitingNo Results AvailableUser ExperienceOther: Evaluation formhttps://ClinicalTrials.gov/show/NCT01473238
8349383493Can Calorie Labels Increase Caloric IntakeWithdrawnNo Results AvailableFood ConsumptionOther: Calorie information|Other: No calorie informationhttps://ClinicalTrials.gov/show/NCT01473225
8349483494BioPoly RS Knee Registry Study for Cartilage Defect ReplacementRecruitingNo Results AvailableCartilage Injury|Defect of Articular Cartilage|Cartilage DamageDevice: BioPoly RS Partial Resurfacing Knee Implanthttps://ClinicalTrials.gov/show/NCT01473199
8349583495Study of Menstrual Irregularities and Endometrial Pathology in Women Undergoing Bariatric SurgeryCompletedNo Results AvailableMorbid Obesity|Endometrial Pathology|Menstrual Irregularitieshttps://ClinicalTrials.gov/show/NCT01473186
8349683496Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: CJ-12420|Drug: Esomeprazole 40mghttps://ClinicalTrials.gov/show/NCT01473173
8349783497Daily Disposable Contact Lens Tear Film StudyCompletedHas ResultsMyopiaDevice: delefilcon A contact lens|Device: narafilcon A contact lenshttps://ClinicalTrials.gov/show/NCT01473160
8349883498Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic PatientsCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Exenatide|Drug: Normal salinehttps://ClinicalTrials.gov/show/NCT01473147
8349983499[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01473134
8350083500Hepatocellular Carcinoma Registry for Turkey (3K Trial)RecruitingNo Results AvailableHepatocellular CarcinomaOther: No Interventionhttps://ClinicalTrials.gov/show/NCT01473121
8350183501Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862CompletedNo Results AvailableHeart FailureDrug: BAY94-8862 + Placebo + Eplerenone|Drug: BAY94-8862 + Placebo + Eplerenone|Drug: BAY94-8862 + Placebo + Eplerenone|Drug: BAY94-8862 + Placebo + Eplerenone|Drug: BAY94-8862 + Placebo + Eplerenonehttps://ClinicalTrials.gov/show/NCT01473108
8350283502Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant LymphomaRecruitingNo Results AvailableSolid Tumor|Malignant Lymphoma|TumorDrug: ARQ 092https://ClinicalTrials.gov/show/NCT01473095
8350383503Proximal Femoral Nail Antirotation (PFNA) Versus PFNA AugmentationActive, not recruitingNo Results AvailableHip Fractures|Closed Fracture of HipDevice: PFNA Augmentation (Synthes)|Device: PFNA (Synthes)https://ClinicalTrials.gov/show/NCT01473082
8350483504Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy SubjectsTerminatedNo Results AvailableHealthyDrug: JTK-853, ketoconazole|Drug: JTK-853 or Placebohttps://ClinicalTrials.gov/show/NCT01473069
8350583505Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected SubjectsCompletedNo Results AvailableHepatitis C Virus Infection, Response to Therapy ofDrug: JTK-853|Drug: Dose 2 JTK-853|Drug: Dose 3 JTK-853|Drug: Dose 4 JTK-853|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01473056
8350683506Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line TreatmentNo longer availableNo Results AvailableRenal Cell CarcinomaDrug: Axitinibhttps://ClinicalTrials.gov/show/NCT01473043
8350783507Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate TissueActive, not recruitingNo Results AvailableBenign Prostate Tissuehttps://ClinicalTrials.gov/show/NCT01473030
8350883508Improving Mental Health in Diabetes: A Guided Self-Help StudyNot yet recruitingNo Results AvailableType 2 Diabetes|Anxiety|DepressionBehavioral: CBT-based Guided Self-Helphttps://ClinicalTrials.gov/show/NCT01473017
8350983509SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to LiverRecruitingNo Results AvailableStage IV Uveal MelanomaDevice: Sir-Spheres®https://ClinicalTrials.gov/show/NCT01473004
8351083510Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD)CompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: TC-5619-238 5mg|Drug: TC-5619-238 25mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01472991
8351183511Prospective Study of Clostridium Difficile in Children Undergoing ColonoscopyRecruitingNo Results AvailableC. Difficile InfectionDrug: metronidazolehttps://ClinicalTrials.gov/show/NCT01472978
8351283512Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream InfectionRecruitingNo Results AvailableCentral Line-Associated Bloodstream InfectionDrug: ethanol|Drug: heparin-saline placebohttps://ClinicalTrials.gov/show/NCT01472965
8351383513System-level Monitoring of Immune Activation Concerning Susceptibility to Sepsis in Trauma PatientsWithdrawnNo Results AvailableTrauma|Sepsishttps://ClinicalTrials.gov/show/NCT01472952
8351483514Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)CompletedHas ResultsGastroesophageal Reflux DiseaseDrug: SSP-002358 (0.1 mg) + PPI|Drug: SSP-002358 (0.5 mg) + PPI|Drug: SSP-002358 (2.0 mg) + PPI|Drug: Placebo + PPIhttps://ClinicalTrials.gov/show/NCT01472939
8351583515Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)RecruitingNo Results AvailableStrokeDrug: Tenecteplase|Drug: alteplasehttps://ClinicalTrials.gov/show/NCT01472926
8351683516Fibrin Sealant in Bilateral Simultaneous Total Knee Arthroplasty With Focus on Blood Loss, Pain, Swelling and StrengthCompletedNo Results AvailableBlood LossDrug: Fibrin sealant|Drug: Saline waterhttps://ClinicalTrials.gov/show/NCT01472913
83517835172940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory AcneCompletedNo Results AvailableAcne VulgarisDevice: 2940 nm Er:YAG laser (DualisXS M002-2A, Fotona®, Fotona d.d, Ljubljana, Slovenia)|Drug: Benzoyl Peroxide gelhttps://ClinicalTrials.gov/show/NCT01472900
8351883518SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) PatientsActive, not recruitingNo Results AvailableDiffuse Large B-cell LymphomaDrug: SAR3419https://ClinicalTrials.gov/show/NCT01472887
8351983519Single Daily Dosage of Trientine for Maintenance Treatment for Wilson DiseaseCompletedHas ResultsWilson DiseaseDrug: Once a day Trientinehttps://ClinicalTrials.gov/show/NCT01472874
8352083520Autologous Endometrial Coculture (AECCT)TerminatedNo Results AvailableInfertilityProcedure: AECC (Autologous endometrial coculture)|Other: no endometrial biopsy or Autologous endometrial coculture (AECC) performedhttps://ClinicalTrials.gov/show/NCT01472861

* Görseller ve İçerik tekif hakkına sahip olabilir